Singapore markets closed
  • Straits Times Index

    3,061.35
    -15.09 (-0.49%)
     
  • Nikkei

    30,248.81
    +609.41 (+2.06%)
     
  • Hang Seng

    24,192.16
    -318.82 (-1.30%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • BTC-USD

    41,454.20
    -528.62 (-1.26%)
     
  • CMC Crypto 200

    1,067.20
    -35.86 (-3.25%)
     
  • S&P 500

    4,455.48
    +6.50 (+0.15%)
     
  • Dow

    34,798.00
    +33.18 (+0.10%)
     
  • Nasdaq

    15,047.70
    -4.54 (-0.03%)
     
  • Gold

    1,750.60
    +0.80 (+0.05%)
     
  • Crude Oil

    73.95
    +0.65 (+0.89%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • FTSE Bursa Malaysia

    1,532.06
    -7.28 (-0.47%)
     
  • Jakarta Composite Index

    6,144.81
    +2.10 (+0.03%)
     
  • PSE Index

    6,951.53
    +36.25 (+0.52%)
     

electroCore to Present at Investor Conferences in June

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

ROCKAWAY, NJ, May 26, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today that its management team will present a several investor conferences during the month of June. The conferencing details are as follows:

Summer Solstice Best Ideas Conference
Date: Tuesday, June 1, 2021
Time: 09:30 AM EDT
Investors can register for the conference HERE.

LD Micro Invitational XI:
Date: Tuesday, June 8, 2020
Time: 3:30 PM EDT
Investors can register for the conference HERE.

JMP Securities Life Sciences Conference:
Date: Thursday, June 17, 2021
Time: 12:30 PM EDT
Investors can register for the conference HERE.

Dan Goldberger, electroCore’s Chief Executive Officer, and Brian Posner, Chief Financial Officer, will provide an overview of the Company’s during a live presentation and will host virtual one-on-one meetings throughout the day.

About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

CONTACT: Investors: Rich Cockrell CG Capital 404-736-3838 ecor@cg.capital or Media Contact: Summer Diaz electroCore 816-401-6333 summer.diaz@electrocore.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting